REGISTERED
on 22 Oct 2024
Last Applicant/ Owned by
601 Walnut Street, Suite 440
Philadelphia
PA
19106
Serial Number
97597040 filed on 19th Sep 2022
Registration Number
7545537 registered on 22nd Oct 2024
Correspondent Address
Zachary J. Holdsman
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
GOLDSPIRE
Scientific research, design and development of personalized whole tumor-derived cell-based autologous immunotherapies for the treatment of cancers; providing a proprietary technology platform for the development of pharmaceutical products and devices featuring technology capable of eliciting anti-tumor responses via the release of tumor antigenic signatures and immunostimulatory factors that activ Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Scientific research, design and development of personalized whole tumor-derived cell-based autologous immunotherapies for the treatment of cancers; providing a proprietary technology platform for the development of pharmaceutical products and devices featuring technology capable of eliciting anti-tumor responses via the release of tumor antigenic signatures and immunostimulatory factors that activate the adaptive immune system against tumor cells
First Use Date in General
05th Dec 2022
First Use Date in Commerce
05th Dec 2022
Mark Details
Serial Number
No 97597040
Mark Type
No Service Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 22nd Oct 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 22nd Oct 2024 | REGISTERED-PRINCIPAL REGISTER |
| 19th Sep 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 19th Sep 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 29th Aug 2024 | ASSIGNED TO EXAMINER |
| 30th Apr 2024 | STATEMENT OF USE PROCESSING COMPLETE |
| 30th Apr 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 09th Apr 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 09th Apr 2024 | TEAS STATEMENT OF USE RECEIVED |
| 09th Apr 2024 | USE AMENDMENT FILED |